REVTORPYK became commercially available on September 30th for the treatment of patients with HR+/HER2- PIK3CA wild-type locally advanced or ...
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the release of findings from a new survey showing that adults with ...
Celcuity (NASDAQ:CELC) reported a wider third-quarter loss as it prepared to commercialize its breast cancer treatment ...
Eton Pharmaceuticals (NASDAQ:ETON) reported third-quarter revenue of $57.9 million, up 158% from a year earlier, and raised ...
NBC News producer Susan Kroll pursued dramatic lifestyle changes after tests showed early signs associated with Alzheimer’s disease. Here’s where the research stands.
A review led by Professor Weidong Zhang at the School of Pharmacy, Naval Medical University, was published in Volume 2 of the ...
Results from a clinical trial funded by the National Institutes of Health (NIH) in five major United States cities show that ...
De nouvelles données sur les néoplasmes myéloprolifératifs porteront notamment sur l’INCA033989, anticorps monoclonal pionnier ciblant la calréticuline mutée , développé par Incyte, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results